ClinicalTrials.gg
Not yet recruitingNCT07875725Updated Oct 15, 2026

Wearable Knee-Assisted Rehabilitation for Range of Motion and Muscle Strength After Total Knee Arthroplasty

An interventional study of ReBK Wearable Telerehabilitation System and Standard Home-Based Rehabilitation in Total Knee Arthroplasty Recovery and Knee Osteoarthritis, sponsored by University of Chile. Not yet recruiting at 3 sites in Chile. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by University of Chile · Not applicable, Interventional, and Treatment

Updated Oct 15, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

This randomized controlled trial evaluates a wearable electrogoniometry-based telerehabilitation system designed to support recovery after total knee arthroplasty. Participants follow the same home-based rehabilitation exercise program and are randomly assigned to an intervention or control group. Participants in the intervention group additionally use a wearable knee device connected to a digital application that provides guidance and real-time feedback during exercise and allows remote monitoring of rehabilitation. Knee range of motion, functional performance, and isometric quadriceps strength are assessed before surgery and during the 12-week postoperative follow-up. The study compares recovery between patients using the technology-assisted rehabilitation system and those following the conventional home-based rehabilitation program.

Read the detailed description

Participants are randomly assigned to either the control group or the intervention group. Both groups follow the same standardized home-based rehabilitation exercise program after total knee arthroplasty. Participants assigned to the intervention group additionally use the wearable electrogoniometry-based telerehabilitation system during their rehabilitation exercises.

Clinical and functional outcomes are assessed throughout the 12-week postoperative follow-up. Assessments include knee range of motion, functional performance, and isometric quadriceps strength. Isometric quadriceps strength is measured using a Tindeq dynamometer and recorded in kilograms at baseline, postoperative week 1, week 4, week 8, and approximately week 12. Participants also complete self-reported assessments, and participants in the intervention group complete an additional questionnaire evaluating usability and their experience with the technology-assisted rehabilitation system.

02

Conditions studied

  • Total Knee Arthroplasty Recovery
  • Knee Osteoarthritis

Keywords

  • Telerehabilitation
  • Total Knee Arthroplasty
  • Wearable Technology
  • Electrogoniometry
  • Range of Motion
  • Quadriceps Strength
  • Home-Based Rehabilitation
03

In context

Osteoarthritis, Knee

3,391 studies on the registry are indexed under Osteoarthritis, Knee; 628 are open to participants now.

This study's planned enrollment of 80 is above the median of 69 across 2,808 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

University of Chile is the lead sponsor of 194 studies on the registry; 38 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults older than 60 years scheduled for primary total knee arthroplasty for knee osteoarthritis.
  • Ability to attend postoperative follow-up assessments.

Exclusion criteria

Exclusion Criteria:

  • Revision arthroplasty.
  • Use of constrained implants.
  • Cognitive impairment preventing adherence to rehabilitation instructions.
  • Inability to participate in follow-up assessments.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Active comparator
    Control group

    Participants receive the standard postoperative rehabilitation program after total knee arthroplasty and perform the prescribed home-based exercises without using the wearable telerehabilitation system.

    Behavioral: Standard Home-Based Rehabilitation

  • Experimental
    Wearable Telerehabilitation Group

    Participants receive the same standard postoperative rehabilitation program and perform the prescribed home-based exercises using the wearable knee device connected to the telerehabilitation application, which provides exercise guidance, real-time feedback, and remote monitoring.

    Device: ReBK Wearable Telerehabilitation System · Behavioral: Standard Home-Based Rehabilitation

Interventions

  • DeviceReBK Wearable Telerehabilitation System

    Participants use the ReBK wearable telerehabilitation system during prescribed home-based rehabilitation exercises. The system consists of a sensorized knee device connected to a digital application that provides guided exercise, real-time feedback based on knee movement, and remote monitoring of rehabilitation progress.

  • BehavioralStandard Home-Based Rehabilitation

    articipants follow the standard postoperative rehabilitation program after total knee arthroplasty and perform the prescribed home-based exercises without using the ReBK wearable telerehabilitation system.

06

What researchers measure

Primary outcomes

  1. Active Knee Flexion Range of Motion

    Active knee flexion range of motion, measured in degrees using a 360° universal goniometer. Three measurements are performed and the average value is recorded.

    Time frame: Preoperative baseline, weekly during postoperative weeks 1-8, and postoperative week 12.

  2. Passive Knee Flexion Range of Motion

    Passive knee flexion range of motion, measured in degrees using a 360° universal goniometer. Three measurements are performed and the average value is recorded.

    Time frame: Preoperative baseline, weekly during postoperative weeks 1-8, and postoperative week 12

  3. Active Knee Extension Range of Motion

    Active knee extension range of motion, measured in degrees using a 360° universal goniometer. Three measurements are performed and the average value is recorded

    Time frame: Preoperative baseline, weekly during postoperative weeks 1-8, and postoperative week 12

  4. Passive Knee Extension Range of Motion

    Passive knee extension range of motion, measured in degrees using a 360° universal goniometer. Three measurements are performed and the average value is recorded.

    Time frame: Preoperative baseline, weekly during postoperative weeks 1-8, and postoperative week 12

  5. Isometric Quadriceps Strength

    Isometric quadriceps muscle strength of the operated limb, measured in kilograms using a Tindeq dynamometer

    Time frame: Preoperative baseline and postoperative weeks 1, 4, 8, and approximately 12

Secondary outcomes

  1. 30-Second Sit-to-Stand Test

    Functional performance assessed using the 30-second Sit-to-Stand test. The number of complete sit-to-stand repetitions performed within 30 seconds is recorded

    Time frame: Preoperative baseline, weekly during postoperative weeks 1-8, and postoperative week 12

  2. Usability of the Technology-Assisted Rehabilitation System

    Usability of the wearable electrogoniometry-based telerehabilitation system assessed using a structured patient questionnaire. Items were rated on a 5-point Likert scale, with higher scores indicating more favorable usability ratings.

    Time frame: Postoperative week 12

07

Study locations

3 sites
  • Hospital Dr. Franco Ravera Zunino
    Rancagua, Región del Libertador General Bernardo O’Higgins rancagua, Chile
  • Hospital Clinico Universidad de Chile
    Santiago, Santiago Metropolitan santiago, Chile
    • Macarena A Barahona, PT · Contact · maca.b.v@gmail.com · +56999054293
    • Hachi Manzur, MD · Principal investigator
    • Maximiliano Barahona, MD · Sub investigator
  • Hospital Las Higueras de Talcahuano
    Talcahuano, Chile
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported in the published article will be made available upon reasonable request.

Time frame: ata will be available following publication of the study results, with no predetermined end date

Access criteria: De-identified data will be available to qualified researchers upon reasonable request to the corresponding author. Requests should include the purpose of the proposed research and will be evaluated by the study investigators, subject to applicable ethical and confidentiality requirements

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07875725
Responsible party
maximiliano barahona vasquez (Co-Investigator, University of Chile) — Principal investigator
First posted
Oct 15, 2026
Start date
Sep 21, 2026 (estimated)
Primary completion
Sep 30, 2027 (estimated)
Completion
Sep 30, 2027 (estimated)
Last update
Oct 15, 2026

Study contacts

Macarena A Barahona, PT
Contact
maca.b.v@gmail.com
+56999054293
Hachi Manzur, MD
principal investigator · University of Chile

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion